Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $13.6 million.

  • Merit Medical Systems' Share-based Compensation rose 10277.07% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.1 million, marking a year-over-year increase of 7280.02%. This contributed to the annual value of $28.5 million for FY2024, which is 3359.58% up from last year.
  • According to the latest figures from Q3 2025, Merit Medical Systems' Share-based Compensation is $13.6 million, which was up 10277.07% from $10.9 million recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' Share-based Compensation peaked at $13.6 million during Q3 2025, and registered a low of $3.1 million during Q2 2021.
  • Over the past 5 years, Merit Medical Systems' median Share-based Compensation value was $5.2 million (recorded in 2024), while the average stood at $6.2 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 1449.81% in 2023, then soared by 10277.07% in 2025.
  • Merit Medical Systems' Share-based Compensation (Quarter) stood at $4.5 million in 2021, then fell by 3.55% to $4.4 million in 2022, then surged by 37.6% to $6.0 million in 2023, then surged by 59.38% to $9.5 million in 2024, then surged by 42.65% to $13.6 million in 2025.
  • Its Share-based Compensation stands at $13.6 million for Q3 2025, versus $10.9 million for Q2 2025 and $9.1 million for Q1 2025.